{
    "title": "Novavax's COVID vaccine shows long-term efficacy in UK trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10562089/Novavaxs-COVID-vaccine-shows-long-term-efficacy-UK-trial.html",
    "date": "2022-02-28",
    "keywords": [
        "vaccine",
        "covid19",
        "efficacy",
        "protection",
        "company",
        "monday",
        "analysis",
        "latestage",
        "infection",
        "disease",
        "quarter",
        "trial",
        "month",
        "inc",
        "study",
        "kingdom",
        "coronavirus",
        "nvxcov2373",
        "period",
        "delta",
        "omicron",
        "novavax",
        "shot",
        "scale",
        "revenue",
        "year",
        "virus",
        "transmission",
        "prevent",
        "president",
        "research",
        "development",
        "level",
        "safety",
        "profile",
        "timeframe",
        "britain",
        "use",
        "food",
        "drug",
        "administration",
        "union",
        "world",
        "health",
        "organization",
        "indonesia",
        "roy",
        "bengaluru",
        "carl",
        "york",
        "editing",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}